rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2006-5-10
|
pubmed:abstractText |
Sepsis, affecting millions of individuals annually with an associated high mortality rate, is among the top 10 causes of death. In addition, improvements in diagnostic tests for detecting and monitoring sepsis and infection have been limited in the last 25 years. Neutrophil CD64 expression has been proposed as an improved diagnostic test for the evaluation of infection and sepsis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1543-2165
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
130
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
654-61
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16683883-Blood Sedimentation,
pubmed-meshheading:16683883-C-Reactive Protein,
pubmed-meshheading:16683883-Diagnosis, Differential,
pubmed-meshheading:16683883-Emergency Medicine,
pubmed-meshheading:16683883-Flow Cytometry,
pubmed-meshheading:16683883-Humans,
pubmed-meshheading:16683883-Infection,
pubmed-meshheading:16683883-Leukocyte Count,
pubmed-meshheading:16683883-Myeloid Cells,
pubmed-meshheading:16683883-Neutrophils,
pubmed-meshheading:16683883-Prospective Studies,
pubmed-meshheading:16683883-Receptors, IgG,
pubmed-meshheading:16683883-Retrospective Studies,
pubmed-meshheading:16683883-Sensitivity and Specificity,
pubmed-meshheading:16683883-Sepsis
|
pubmed:year |
2006
|
pubmed:articleTitle |
Neutrophil CD64 is an improved indicator of infection or sepsis in emergency department patients.
|
pubmed:affiliation |
Trillium Diagnostics, LLC, Maine Medical Center Research Institute, Scarborough, ME, USA. brucedavis@trilliumdx.com
|
pubmed:publicationType |
Journal Article,
Comparative Study
|